CLINICAL NEWS
In a recent study, researchers find reasons why a significant number of US adults are at risk of unintentionally overdosing on over-the-counter pain medications. » More |
CONTINUING EDUCATION
Late-life depression can occur in up to 50% of patients. Pharmacists can screen for unidentified cases and advocate for routine measurement of symptom severity.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. |
ADVERTISEMENT
New Drug Price Type Options:
White Paper
Two new and different methods to ascertain true drug acquisition cost can save money on Rx drug benefits. Read white paper for details and comparison of NADAC and PAC. |
EDITOR’S PICK
Multiple sclerosis
Read about pharmaceuticals in late-stage development for the treatment of multiple sclerosis, as well as view selected literature and websites that provide the latest information about the disease. » Click here. |
CLINICAL NEWS
Nonsteroidal anti-inflammatory drugs may prevent the development of skin cancer, according to a new study, published online first in the journal Cancer on May 29. » More |
Investigational afatinib used in non-small cell lung cancer treatment helped patients live longer compared with pemetrexed/cisplatin, according to the results of a new phase 3 clinical trial. » More |
Men with advanced prostate cancer treated with investigational enzalutamide (formerly MDV3100) demonstrated a significantly higher response rate in health-related quality of life compared with placebo, according to new data from the phase 3 AFFIRM study. » More |
Survey
a) Highly effective
b) Somewhat effective
c) Neutral
d) Somewhat ineffective
e) Largely ineffective
Click here and see what your colleagues think, too.
Want to see the results of our last survey about specialty pharmacy services? Click here. |
|
Confirm your
e-newsletter subscription click here.
To ensure future delivery of email newsletters from Formulary please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff |
Digital Edition |
|
|